SOLIGENIX, INC. (SNGX): Nasdaq/NYSE listing notice — Soligenix receives Nasdaq deficiency notice for stockholders' equity below $2.5M

SOLIGENIX, INC.

Stockholders' equity of $1,828,951 as of June 30, 2025, below Nasdaq's $2.5M minimum.
July 1 ATM sale raised ~$1.44M gross, but company still fails alternative listing standards.
Must submit compliance plan by Sept 29, 2025; if accepted, Nasdaq may extend up to 180 days.
Failure to regain compliance could lead to delisting; company may appeal to Nasdaq panel.
Common stock continues trading on Nasdaq Capital Market under SNGX pending plan.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

SOLIGENIX, INC. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 5550(b)(1)

Exact text from the filing

August 15, 2025, Soligenix, Inc. (the “Company”) received notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that it is not in compliance with the minimum stockholders’ equity requirement for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(b)(1) requires companies listed on The Nasdaq Capital Market to maintain stockholders’ equity of at least $2,500,000 (the “Stockholders’ Equity Requirement”). In the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, the Company reported stockholders’ equity of $1,828,951

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

SOLIGENIX, INC. filing history →

Source: SEC EDGAR

accession 0001558370-25-011619

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.